The online-only Data Supplement is available at http://circep.ahajournals.org/lookup/suppl/Background-Apamin-sensitive K currents (I KAS ) are upregulated in heart failure. We hypothesize that apamin can flatten action potential duration restitution (APDR) curve and can reduce ventricular fibrillation duration in failing ventricles. Methods and Results-We simultaneously mapped membrane potential and intracellular Ca (Ca i ) in 7 rabbit hearts with pacing-induced heart failure and in 7 normal hearts. A dynamic pacing protocol was used to determine APDR at baseline and after apamin (100 nmol/L) infusion. Apamin did not change APD 80 in normal ventricles, but prolonged APD 80 in failing ventricles at either long (≥300 ms) or short (≤170 ms) pacing cycle length, but not at intermediate pacing cycle length. The maximal slope of APDR curve was 2.03 (95% confidence interval, 1.73-2.32) in failing ventricles and 1.26 (95% confidence interval, 1.13-1.40) in normal ventricles at baseline (P=0.002). After apamin administration, the maximal slope of APDR in failing ventricles decreased to 1.43 (95% confidence interval, 1.01-1.84; P=0.018), whereas no significant changes were observed in normal ventricles. During ventricular fibrillation in failing ventricles, the number of phase singularities (baseline versus apamin, 4.0 versus 2.5), dominant frequency (13.0 versus 10.0 Hz), and ventricular fibrillation duration (160 versus 80 s) were all significantly (P<0.05) decreased by apamin. Conclusions-Apamin prolongs APD at long and short, but not at intermediate pacing cycle length in failing ventricles. I KAS upregulation may be antiarrhythmic by preserving the repolarization reserve at slow heart rate, but is proarrhythmic by steepening the slope of APDR curve, which promotes the generation and maintenance of ventricular fibrillation. (Circ Arrhythm Electrophysiol. 2013;6:410-418.)
H eart failure (HF) is associated with significant electrophysiological remodeling of the repolarization currents, including downregulation of most potassium currents and upregulation of late sodium and sodium-calcium exchange current. 1 These changes tend to prolong action potential duration (APD). On the contrary, the APD in patients or animals with structural heart diseases, including HF, shortens more rapidly than normal ventricles during rapid pacing, leading to increased slope of APD restitution (APDR) curve. 2, 3 A steep APDR curve promotes dynamical instability, wavebreaks, and ventricular fibrillation (VF). [4] [5] [6] [7] [8] The mechanisms by which HF lengthens APD at slow pacing rates but shortens APD and increases the slope of APDR at fast pacing rates remain incompletely understood. One possible explanation is that failing ventricular cells (but not normal ventricular cells) exhibit increased apamin-sensitive small conductance calcium-activated K (SK) current (I KAS ). 9 The SK channels are first discovered in the brain, 10 but it is also known to play an important role in cardiac repolarization. 9, 11, 12 The importance of I KAS in human ventricular repolarization is further documented by studies in the cells isolated from the native hearts of the transplant recipients. 13 The latter study showed that blocking I KAS by apamin lengthens the APD of failing human ventricular myocyte by an average of 11.8%. Because multiple other K currents are downregulated in HF, 1 upregulation of I KAS plays an important role in ventricular repolarization in failing ventricles. The SK channel is sensitive to intracellular calcium (Ca i ). Because rapid pacing causes Ca i accumulation, I KAS activation in failing but not normal ventricles could lead to more APD shortening at rapid pacing rate and steepened APDR curve. If this is true, then I KAS blockade by apamin (a specific I KAS blocker) 14 should flatten the APDR, reduce wavebreaks, and hinder the maintenance of VF. To determine the importance of I KAS on APDR, we simultaneously mapped the membrane potential (V m ) and Ca i in normal and failing ventricles at different pacing cycle lengths (PCLs) before and after apamin administration. We also studied the wavebreaks and the duration of pacing-induced VF in these hearts. The results were used to test the hypotheses that (1) I KAS activation promotes steeper APDR in failing ventricles and (2) that I KAS blockade by apamin flattens APDR curve, prevents wavebreaks, and shortens VF duration in failing ventricles.
Methods
This study protocol was approved by the Institutional Animal Care and Use Committee of Indiana University School of Medicine and the Methodist Research Institute, and conforms to the Guide for the Care and Use of Laboratory Animals. 15 New Zealand white female rabbits (N=27) were used. We attempted to induce HF in 10 rabbits by rapid pacing. Among them, 7 completed the pacing protocol and developed HF. The remaining 3 rabbits died 1.7 (95% confidence interval [CI], 0.2-3.1) days after the onset of tachycardia pacing at 250 beats per minute. We studied 7 normal rabbit hearts as controls. The other 10 hearts were used for Western blot analyses (5 with pacing-induced HF and 5 normal controls). A detailed method section is included in the online-only Data Supplement.
Pacing-Induced HF and Optical Mapping
Rapid ventricular pacing was used to induce HF. 9 The hearts were Langendorff perfused at 25 to 35 mL/min with oxygenated Tyrode's solution (in mmol/L: NaCl 125, KCl 4.5, NaHCO 3 24, NaH 2 PO 4 1.8, CaCl 2 1.8, MgCl 2 0.5, and glucose 5.5) with a pH of 7.40. The hearts were stained with Rhod-2 AM (1.48 μmol/L) for Ca i and RH237 (10 μmol/L) for V m mapping. The double-stained hearts were illuminated with a laser at 532 nm wavelength. The fluorescence was filtered and recorded simultaneously 2 ms/frame and 100×100 pixels with a spatial resolution of 0.35×0.35 mm 2 per pixel. Optical signals were processed with both spatial (3×3 pixels Gaussian filter) and temporal (3 frames moving average) filtering. Phase mapping was performed to evaluate the location and evolution of phase singularities.
Statistical Analysis
Data are presented as mean and 95% CI. Wilcoxon rank-sum test was used to compare the data within and between groups. Categorical parameters between groups were compared by Fisher exact test. Pearson correlation coefficient was used to measure the association of continuous measures. The P values are corrected for multiple comparison in relevant analyses using Bonferonni adjustment. A 2-sided P value of ≤0.05 was considered statistically significant.
Results
All rabbits that survived the rapid pacing protocol showed clinical signs of HF, including appetite loss, tachypnea, lethargy, pleural effusion, ascites, and visible congestion of lung, liver, and gastrointestinal tract. HF ventricles demonstrated significant increases in left ventricular end-diastolic dimension (12.7 P=0.012). Figure 1 shows the marked cardiac enlargement typical for all failing hearts.
PCL and APD Prolongation Induced by Apamin
An unexpected finding is that blocking I KAS by apamin results in ventricular APD 80 prolongation only with very short and very long PCLs, but not with intermediate PCLs. At baseline, HF ventricles have longer APD 80 than normal ventricles at all PCLs ( Figure 1A and 1B) . Apamin administration did not prolong APD 80 Figure  1C ). Here, the P values are already adjusted by Bonferroni correction. In Figure 1C , 9 of the 11 comparisons are statistically significant. In Figure 1D , all the P values remained nonsignificant (>0.05). The effects of apamin on the percentage of APD 80 prolongation were PCL dependent ( Figure  2 ). After adding apamin, the HF ventricles have larger percentage of APD 80 prolongation than normal ventricles. The effects were more apparent at very long PCLs ( , the differences between normal and failing ventricles were not significant ( Figure 2 ).
Secondary Rise of Ca i in HF Ventricles
In 4 of the 7 HF ventricles, we observed that the initial short Ca i transient was followed by a secondary rise of Ca i when paced at 350 ms PCL ( Figure 3A , red arrows at site a). Apamin administration lengthened APD 80 and widened the initial phase of Ca i transient, making the secondary rise of Ca i less apparent ( Figure 3A , black arrows at site a). However, apamin could also induce secondary rise of Ca i in areas without secondary rise of Ca i at baseline ( Figure 3A , site b). Figure 3B shows the area of the mapped region exhibiting secondary rise of Ca i in these 4 HF ventricles at PCL 350 ms. Before apamin infusion, the area averaged 19% (95% CI, −3 to 41) of epicardial surface of 4 HF ventricles ( Figure  3B , areas encircled by blue line). After apamin, the area with secondary rise of Ca i (Figure 3B , areas encircled by green line) decreased to 9% (95% CI, −1 to 18; P=0. 25) . Apamin infusion could induce secondary rise of Ca i in 6% (95% CI, −4 to 16) of the mapped areas where no secondary rise of Ca i was observed at baseline. Baseline APD 80 at PCL 350 ms averaged 216 ms (95% CI, 188-243) in areas without Ca i rise area and 245 ms (95% CI, 201-289) in areas with Ca i rise (P=0.12). In 4 HF ventricles with secondary rises of Ca i at PCL 350 ms, the SD of APD 80 was decreased from 17 ms (95% CI, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] to 10 ms (95% CI, 6-13) by apamin (P=0.037). In contrast, in the remaining 3 HF ventricles without secondary rises of Ca i at PCL 350 ms, the SD of APD 80 was not significantly changed by apamin (baseline: 10 ms [95% CI, 1-19], apamin: 7 ms [95% CI, 1-13], P=0.068). The HF ventricles with secondary rise of Ca i (N=4) showed increased thickness of interventricular septum after tachycardia pacing (by 36% [95% CI, −17 to 88]). In comparison, the HF ventricles without secondary rise of Ca i (N=3) showed a reduction of the thickness of interventricular septum (−37% [95% CI, −60 to −14], P=0.034). None of the 7 normal ventricles showed secondary rises of Ca i at any PCL (P=0.021). Apamin did not prolong the APD 80 or change action potential morphology in any normal ventricles.
Effects of Apamin on Spatial Heterogeneity of APD
Long PCLs are also associated with significant spatial heterogeneity of APD in failing ventricles. We used the SD of APD 80 at all mapped pixels to measure the spatial heterogeneity of APD. Figure 4 shows the APD 80 maps before and after apamin infusion in normal ( Figure 4A ) and HF ventricles (Figure 4B) at 300 ms PCL. At baseline, APD 80 distribution is more heterogeneous in HF than normal ventricles ( Figure 4A and 4B). The average SD of APD 80 was consistently higher in HF than normal ventricles (at PCL 350 ms, HF: 14 ms [95% CI, [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] [19] , normal: 8 ms [95% CI, 7-9], P=0.04; at PCL 300 ms, HF: 10 ms [95% CI, 7-12], normal: 7 ms [95% CI, 6-8], P=0.048; Figure 4C and 4D, asterisks). In normal ventricles, apamin did not change the SD of APD 80 at any PCL ( Figure 4C ). In HF ventricles after apamin infusion, APD 80 distribution became more homogenous than baseline ( Figure  4B ). The SD of APD 80 was consistently decreased by apamin ( Figure 4D ). Furthermore, the SDs after apamin in HF and normal ventricles were not statistically different ( 
Correlation Between ∆APD and Baseline APD
APD difference (∆APD, apamin-treated APD 80 minus baseline APD 80 ) maps were used to characterize the 2-dimensional distribution of I KAS ( Figure 5 ). In normal ventricles, apamin did not significantly prolong the APD 80 . The ∆APD map showed variable changes of APD 80 , including areas of APD 80 shortening (blue) and prolongation (green; Figure 5A ). In HF ventricles, the ∆APD map showed greater and more heterogeneously distributed ∆APD than normal ventricles ( Figure 5B ). Figure 5D ). The negative correlation indicates that apamin induces more APD 80 prolongation in areas with short APD 80 than with long APD 80 at baseline.
Effect of Apamin on the Maximal Slope of APDR Curves
APDR curves were sampled at a basal (site a), a middle (site b), and an apical (site c) area in each heart studied ( Figure  6A and 6B) . In a representative HF ventricle ( Figure 6A) , APDR curve at these 3 sites ( Figure 6A , top) consistently showed that apamin prolonged APD 80 at both very long (350 and 300 ms) and short (160 ms) PCLs, leading to a steepened APDR at long PCL and a flattened APDR at short PCL. In a representative normal ventricle ( Figure 6B) (Figure 6C , asterisk). After apamin infusion, the maximal slope of APDR decreased significantly in failing ventricles ( Figure 6C ), whereas the maximal slope did not change in normal ventricles ( Figure 6D ).
Effect of Apamin on VF Dynamics in Failing Ventricles
At baseline, VF was inducible in all 7 HF ventricles, but in only 1 of the 7 normal ventricles (P<0.01). A total of 36 VF episodes (9 at baseline, 27 after apamin) were induced in HF ventricles. Figure 7A shows the p-ECG recordings of VF at baseline and after apamin infusion in a HF ventricle.
The dominant frequency of VF was decreased from 13.0 Hz (95% CI, 8.2-17.8) at baseline to 10.0 Hz (95% CI, 6.8-13.2) after apamin infusion (P=0.028; Figure 7B ). Consecutive phase maps sampled at 20-ms intervals during VF were analyzed for phase singularities (wavebreaks). Figure  7C shows consecutive phase maps with phase singularities (black arrows) at baseline and after apamin infusion in a failing ventricle. Apamin decreased the number of phase singularities (P=0.028; Figure 7D ). Figure 8 shows the outcomes of VF episodes in HF ventricles. At baseline, most (8 of 9) VF were shock-terminated (>180 s in duration) episodes ( Figure 8A , top and Figure 8B ). After apamin infusion, most (15 of 27) VF became self-terminated (<180 s in duration) episodes ( Figure 8A , bottom and Figure 8B ; P=0.026). We defined 180 s as the duration of VF if VF did not terminate at that time. The VF duration was decreased from 160 s (95% CI, 112-209) at baseline to 80 s (95% CI, 8-151) after apamin infusion in HF ventricles (P=0.043; Figure 8C ). Furthermore, there is a positive correlation between SD of APD 80 at all mapped pixels and the duration of VF in failing ventricles (at PCL 300 ms, r=0.57, P=0.03; at PCL 260 ms, r=0.61, P=0.02).
Discussion
We found that I KAS activation is important in preserving repolarization reserve of failing ventricles at slow heart rates. However, I KAS activation is also a major factor that underlies the repolarization heterogeneity. At very short PCLs, Ca i accumulation activates I KAS and steepens the APDR curve, which facilitates the generation and maintenance of VF. Apamin flattens the APDR at short PCL, decreases wavebreaks during VF activation, reduces the dominant frequency of VF and shortens the duration of VF. These findings suggest that I KAS blockade can potentially be antiarrhythmic by flattening APDR, but proarrhythmic by prolonging APD during bradycardia in failing ventricles. Figure 5 . Effects of apamin on the correlation between delta action potential duration (∆APD, apamin-treated APD 80 minus baseline APD 80 ) and baseline APD 80 in normal and heart failure (HF) ventricles. Baseline APD 80 map and ∆APD maps of all normal (A) and HF (B) ventricles at pacing cycle lengths (PCL) 300 ms. In HF ventricles (B), apamin prolonged APD 80 in a heterogeneous manner, leading to a heterogeneously distributed APDprolonging area. C, Correlation between ∆APD and baseline APD 80 in a HF and a normal ventricle at PCL 300 ms. The longer the baseline APD, the smaller the ∆APD. D, Correlation coefficient (r) between ∆APD and baseline APD 80 in 7 HF and 7 normal ventricles. Note that HF ventricles have steeper (negative) r than normal ventricles at PCL 350 and 300 ms. Small squares in the data box indicate the mean value.
Secondary Rise of Ca i at Long PCLs
Secondary rise of Ca i during the late action potential plateau is commonly observed in HF but not normal ventricular cells. 16 The mechanism of secondary rise of Ca i is attributed to reduced sarcoplasmic reticulum Ca release, resulting in less Cainduced inactivation of L-type Ca current (I Ca,L ) at the phases 2 and 3 of the action potential. 17 As repolarization continues, the driving force for Ca entry increases and promotes greater Ca entry and additional sarcoplasmic reticulum Ca release during the latter phase of the plateau. Under these conditions, the combination of the increased late I Ca,L , together with increased Na-Ca exchange current (I NCX ), causes further APD prolongation. In the present study, we showed that nearly 20% of the epicardial cells demonstrated secondary rises of Ca i . These same areas also had longer baseline APD 80 , which was less responsive to apamin, compared with areas without secondary Ca i rises, although the differences were not statistically significant. A possible explanation is that these areas exhibited less upregulation of I KAS than areas without secondary Ca i rises (ie, in the areas without secondary Ca i rises, the upregulation of I KAS was sufficient to compensate for the increased inward currents, preventing the secondary Ca i rises and APD prolongation). This notion is supported by the observation that I KAS blocker can induce secondary rise of Ca i in nearly 6% of the mapped areas where no secondary rise of Ca i was observed at baseline in failing ventricle. Electrophysiological heterogeneity is commonly observed in failing ventricles, and contributes to the mechanisms of arrhythmogenesis. 1, 18, 19 These heterogeneities are related in part to the differential remodeling of various K channels transmurally. In this study, we found that significant heterogeneity of APD is also present in different regions of the epicardium in failing ventricles at long PCL, which was decreased by apamin. These findings suggest that heterogeneous I KAS upregulation contributes to the repolarization heterogeneity in failing ventricles.
I KAS at Short and Long PCLs
The ventricular APD and the diastolic interval both shorten during rapid pacing. The relationship between APD and the previous diastolic interval can be used to construct an APDR curve. 20 The APDR curve can be measured experimentally by delivering a single extrastimulus after a train of stimuli (extrastimulus technique) or by dynamic pacing protocol with progressively shortened PCL (dynamic pacing technique). 6 As compared with the APDR curve determined by extrastimulus techniques, the dynamic protocol generates steeper slopes of the APDR curve that better mimic APD dynamics during rapid ventricular arrhythmias, such as VF. 6 In the present study using dynamic pacing protocol, we found that APD shortening at very short PCL could be prevented by I KAS inhibition, consistent with the hypothesis that short PCL causes Ca i accumulation and activates I KAS , leading to a steeper APDR. 9 If Ca i accumulation is important for APD response to rapid pacing, then epicardial cells of the failing ventricles should exhibit greater shortening of APD in failing ventricles because those cells have the highest expression of I KAS . 9 The latter prediction was confirmed by Harada et al, 21 who reported that epicardium of the failing rabbit ventricles undergoes significant APD shortening at short PCL, and that shortened APD is important to the generation of ventricular arrhythmias in that model.
A steep slope of APDR curve is associated with increased propensity for cardiac arrhythmias. 4, 5, 20, 22 In the present study, I KAS inhibition flattened the APDRs, which in turn decreased wavebreaks, shortened VF durations, and hindered the maintenance of VF. Taken together, these data suggest that upregulation of I KAS in HF ventricles plays important roles of APD shortening during rapid pacing, which in turn steepens the slope of APDR curve and promotes the initiation and maintenance of VF.
We also found that apamin significantly lengthens APD and steepens the APDR curve at long PCL, suggesting I KAS is also important for ventricular repolarization at slow heart rates. A possible explanation is that failing hearts have increased intracellular Na concentration. At slow pacing rates, the reverse mode of NCX current may promote Ca i transport and sarcoplasmic reticulum Ca loading with enhanced sarcoplasmic reticulum Ca release. 23, 24 The increased Ca i results in more I KAS activation. Apamin, therefore, has greater effects at very long PCL than at the intermediate PCL.
Apamin as a Selective Blocker of SK Currents
Apamin is a highly selective blocker of SK currents. 14, 25, 26 Even among the SK channels, apamin only selectively blocks SK2 and SK3. It does not block SK1 at 100 nmol/L, 26 the concentration used in the present study. Due to its subtype selectivity, we have used the term I KAS rather than I K(Ca) to describe the K current that is blocked by apamin. The only other current blocked by apamin is the fetal L-type Ca 2+ current. 27 Blocking that inward current should not prolong the APD as observed in the present study. However, it might explain the APD shortening observed in some areas of normal ventricles after apamin administration. Therefore, we propose that the changes of APD and arrhythmia inducibility after apamin administration are due to the blockade of the currents conducted by SK channels.
Clinical Implications
K currents are vital for cardiac repolarization. Downregulation of the K currents in HF is thought to contribute significantly to reduced repolarization reserve that promotes afterdepolarizations, ventricular arrhythmias, and sudden death. 1, 28 Upregulation of I KAS during bradycardia might increase repolarization reserve and prevent afterdepolarizations. On the contrary, I KAS upregulation at tachycardia (short CL) might shorten APD and steepen APDR, promoting ventricular arrhythmia. Therefore, similar to other K channel blockers, our data suggest that I KAS blockers can be both proarrhythmic and antiarrhythmic, depending on the clinical situations associated with arrhythmogenesis. I KAS blockade may prevent transition from ventricular tachycardia to VF and also prevent the spontaneous reinitiation of VF and electrical storm. 9 On the contrary, if the arrhythmia is bradycardia dependent, such as those induced by early afterdepolarizations, I KAS blockers may promote triggered activity and ventricular arrhythmia.
Study Limitation
A limitation of the study is that the mapping was performed only on the epicardial surface. These findings may not be applicable to midmyocardial or endocardial layers of the cells. A second limitation is that, due to a lack of specific antibody against SK2 channels in rabbits, we were not able to obtain reliable data on SK protein levels in failing rabbit ventricles. We have attempted to use a commercial antibody (Abcam, ab83733) for Western blot analyses of the SK2 protein levels in HF and normal controls rabbit ventricles. Due to low signal:noise ratio, the results showed a statistically insignificant increase of SK2 protein in failing ventricles (see online-only Data Supplement). However, reliable anti-SK2 antibody is available for failing human ventricles. Chang et al 13 showed that the native hearts of transplant recipients have both increased I KAS and SK2 protein concentrations. We did not measure the SK current in this study with patch clamp techniques. However, 2 other studies from our laboratory 9, 13 have documented the presence of apamin-sensitive K currents in failing ventricles using patch clamp techniques.
